Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Rocket Pharmaceuticals Inc
(NQ:
RCKT
)
19.07
-0.52 (-2.65%)
Streaming Delayed Price
Updated: 1:46 PM EDT, Sep 11, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Rocket Pharmaceuticals Inc
< Previous
1
2
3
4
5
6
7
Next >
Rocket Pharmaceuticals Completes Acquisition of Renovacor
December 01, 2022
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
November 28, 2022
Via
Benzinga
Why DraftKings Shares Are Trading Lower By 5%; Here Are 24 Stocks Moving Premarket
November 28, 2022
Gainers Talkspace, Inc. (NASDAQ: TALK) shares rose 48.3% to $0.89 in pre-market trading. Talkspace recently named Jon Cohen as CEO.
Via
Benzinga
Analyst Ratings for Rocket Pharmaceuticals
September 30, 2022
Rocket Pharmaceuticals (NASDAQ:RCKT) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
November 28, 2022
Welcome back, trader! It's time to check out the biggest pre-market stock movers that traders will want to know about on Monday!
Via
InvestorPlace
Rocket Pharmaceuticals to Present at the 5th Annual Evercore ISI HealthCONx Conference
November 21, 2022
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
This Stock Is Up 106% In 2022 And Analysts Love It, But Jim Cramer Says 'There's Too Much Political Risk'
November 15, 2022
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Rocket Pharmaceuticals Inc (NASDAQ: RCKT) is a "very early stage company that has a lot in the pipe. I tend to like these companies."
Via
Benzinga
Why Inotiv Shares Dipped 57%; Here Are 76 Biggest Movers From Yesterday
November 18, 2022
Gainers Satixfy Communications Ltd. (NYSE: SATX) jumped 96.4% to settle at $51.70 on Thursday.
Via
Benzinga
Rocket Pharmaceuticals Reports Third Quarter 2022 Financial Results and Highlights Recent Progress
November 03, 2022
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2022
November 08, 2022
Upgrades
Via
Benzinga
Rocket Pharmaceuticals Announces Presentations Highlighting AAV and Lentiviral Gene Therapies at Upcoming Scientific Congresses
November 03, 2022
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
November 01, 2022
Upgrades
Via
Benzinga
$20 Million Bet On Rocket Pharmaceuticals? 3 Stocks Insiders Are Buying
October 12, 2022
Although US crude oil prices traded lower on Wednesday, there were a few notable insider trades.
Via
Benzinga
Rocket Pharmaceuticals Announces Presentations Highlighting Lentiviral Gene Therapies at the 29th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)
October 12, 2022
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
Rocket Pharmaceuticals to Present at the 2022 Cell & Gene Meeting on the Mesa
October 10, 2022
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
Rocket Pharmaceuticals Announces Pricing of Public Offering of Common Stock
October 03, 2022
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
Rocket Pharmaceuticals Announces Proposed Public Offering of Common Stock
October 03, 2022
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
Citigroup To $47? Plus This Analysts Predict $95 For Papa John's
October 03, 2022
Goldman Sachs cut Citigroup Inc. (NYSE: C) price target from $54 to $47. Citigroup shares fell 0.4% to $41.51 in pre-market trading.
Via
Benzinga
Coca-Cola Price Target Cut By This Analyst? Plus Rocket Pharmaceuticals Likely To Rally Around 306%
October 03, 2022
Wells Fargo cut the price target on The Coca-Cola Company (NYSE: KO) from $72 to $66. Wells Fargo analyst Chris Carey maintained an Overweight rating on the stock. Coca-Cola shares rose 0.3% to $56.20...
Via
Benzinga
Health Care Company Rocket Pharmaceuticals Announces Acquisition of Renovacor
September 30, 2022
Rocket Pharmaceuticals (NASDAQ:RCKT) has announced an acquisition of Renovacor (AMEX:RCOR) that is expected to be completed in Q1 of 2023.
Via
Benzinga
Why F45 Training Shares Climbed 41%; Here Are 84 Biggest Movers From Friday
October 03, 2022
Gainers FingerMotion, Inc. (NASDAQ: FNGR) gained 82.2% to close at $3.37.
Via
Benzinga
Rocket Pharmaceuticals Announces Positive Updates from Phase 1 Clinical Trial for RP-A501 in Danon Disease at the Heart Failure Society of America (HFSA) Annual Scientific Meeting 2022
September 30, 2022
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
Rocket Pharmaceuticals to Present at Chardan 6th Annual Genetic Medicines Conference
September 27, 2022
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates EVOP, STOR, RCKT, RCOR
September 22, 2022
Via
ACCESSWIRE
Why Is Renovacor (RCOR) Stock Up 18% Today?
September 20, 2022
Renovacor (RCOR) stock is gaining on Tuesday after announcing that Rocket Pharmaceuticals (RCKT) is acquiring it in an all-stock deal.
Via
InvestorPlace
Rocket Pharmaceuticals Buys Renovacor, Strengthening Position In Gene Therapies For Heart Diseases
September 20, 2022
Via
Benzinga
RCKT STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Merger of Rocket Pharmaceuticals, Inc. Is Fair to Shareholders
September 20, 2022
From
Halper Sadeh LLC
Via
Business Wire
Rocket Pharmaceuticals to Acquire Renovacor, Extending Leadership in AAV-based Cardiac Gene Therapy
September 20, 2022
From
Rocket Pharmaceuticals, Inc. and Renovacor, Inc.
Via
Business Wire
Rocket Pharmaceuticals to Present Updated Data from Phase 1 Danon Disease Trial for RP-A501 at the Heart Failure Society of America (HFSA) Annual Scientific Meeting 2022
September 16, 2022
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
Why Comera Life Sciences Shares Jumped 101%; Here Are 74 Biggest Movers From Yesterday
September 14, 2022
Gainers Akero Therapeutics, Inc. (NASDAQ: AKRO) shares jumped 136.8% to settle at $29.05 on Tuesday after the company's Phase 2b HARMONY study met its primary endpoint for both the 50mg and 28mg EFX...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.